GHP Investment Advisors Inc. Sells 916 Shares of Plexus Corp. (NASDAQ:PLXS)

GHP Investment Advisors Inc. lessened its holdings in Plexus Corp. (NASDAQ:PLXSFree Report) by 1.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 87,068 shares of the technology company’s stock after selling 916 shares during the quarter. GHP Investment Advisors Inc. owned 0.32% of Plexus worth $11,903,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in PLXS. Quest Partners LLC boosted its stake in shares of Plexus by 36,700.0% during the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after purchasing an additional 367 shares during the period. Innealta Capital LLC bought a new stake in Plexus in the 2nd quarter worth $51,000. EntryPoint Capital LLC increased its position in shares of Plexus by 56.2% in the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after acquiring an additional 351 shares during the period. GAMMA Investing LLC raised its stake in shares of Plexus by 190.1% during the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after acquiring an additional 498 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in shares of Plexus by 12.0% during the second quarter. Signaturefd LLC now owns 1,705 shares of the technology company’s stock worth $176,000 after purchasing an additional 183 shares during the period. 94.45% of the stock is owned by institutional investors.

Insider Transactions at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now owns 9,586 shares of the company’s stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Steven J. Frisch sold 6,565 shares of Plexus stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total value of $841,042.15. Following the transaction, the insider now owns 36,118 shares of the company’s stock, valued at $4,627,076.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,113 shares of company stock valued at $2,541,394 in the last three months. 2.39% of the stock is currently owned by company insiders.

Analyst Ratings Changes

PLXS has been the topic of a number of research analyst reports. Needham & Company LLC boosted their price target on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a report on Friday. Benchmark reissued a “buy” rating and set a $150.00 target price on shares of Plexus in a research note on Monday, October 21st. Finally, KeyCorp began coverage on Plexus in a report on Tuesday. They set a “sector weight” rating for the company. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Plexus presently has a consensus rating of “Hold” and a consensus target price of $129.75.

Read Our Latest Report on Plexus

Plexus Stock Down 2.6 %

Plexus stock traded down $3.70 during trading hours on Friday, hitting $141.19. 318,082 shares of the stock traded hands, compared to its average volume of 128,867. Plexus Corp. has a one year low of $88.57 and a one year high of $153.60. The firm’s 50-day moving average price is $130.82 and its two-hundred day moving average price is $116.13. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07. The company has a market cap of $3.84 billion, a PE ratio of 35.56 and a beta of 0.89.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.44 earnings per share. On average, research analysts forecast that Plexus Corp. will post 3.74 EPS for the current year.

Plexus Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Recommended Stories

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.